Search Results - "Vetro, Joseph A"
-
1
Structure/function relationships of polyamidoamine/DNA dendrimers as gene delivery vehicles
Published in Journal of pharmaceutical sciences (01-02-2005)“…PAMAM dendrimers are members of a class of polyamine polymers that demonstrate significant gene delivery ability. In this study, a selection of PAMAM…”
Get more information
Journal Article -
2
Preliminary evidence that the novel host-derived immunostimulant EP67 can act as a mucosal adjuvant
Published in Clinical immunology (Orlando, Fla.) (01-12-2015)“…Abstract EP67 is a complement component 5a (C5a)-derived peptide agonist of the C5a receptor (CD88) that selectively activates DCs over neutrophils. Systemic…”
Get full text
Journal Article -
3
Surface Modification of Biodegradable Microparticles with the Novel Host-Derived Immunostimulant CPDI-02 Significantly Increases Short-Term and Long-Term Mucosal and Systemic Antibodies against Encapsulated Protein Antigen in Young Naïve Mice after Respiratory Immunization
Published in Pharmaceutics (01-09-2022)“…Generating long-lived mucosal and systemic antibodies through respiratory immunization with protective antigens encapsulated in nanoscale biodegradable…”
Get full text
Journal Article -
4
Direct Comparison of Chol-siRNA Polyplexes and Chol-DsiRNA Polyplexes Targeting STAT3 in a Syngeneic Murine Model of TNBC
Published in Non-coding RNA (13-01-2022)“…RNA interference (RNAi) molecules have tremendous potential for cancer therapy but are limited by insufficient potency after intravenous (IV) administration…”
Get full text
Journal Article -
5
Yeast methionine aminopeptidase type 1 is ribosome-associated and requires its N-terminal zinc finger domain for normal function in vivo
Published in Journal of cellular biochemistry (2002)“…Methionine aminopeptidase type 1 (MetAP1) cotranslationally removes N‐terminal methionine from nascent polypeptides, when the second residue in the primary…”
Get full text
Journal Article -
6
Surface conjugation of EP67 to biodegradable nanoparticles increases the generation of long-lived mucosal and systemic memory T-cells by encapsulated protein vaccine after respiratory immunization and subsequent T-cell-mediated protection against respiratory infection
Published in International journal of pharmaceutics (30-06-2019)“…[Display omitted] Encapsulation of protein vaccines in biodegradable nanoparticles (NP) increases T-cell expansion after mucosal immunization but requires…”
Get full text
Journal Article -
7
Preliminary preclinical study of Chol-DsiRNA polyplexes formed with PLL[30]-PEG[5K] for the RNAi-based therapy of breast cancer
Published in Nanomedicine (01-04-2021)“…RNA interference molecules have tremendous potential for cancer therapy but are limited by insufficient potency after i.v. administration. We previously found…”
Get full text
Journal Article -
8
Encapsulation of an EP67-Conjugated CTL Peptide Vaccine in Nanoscale Biodegradable Particles Increases the Efficacy of Respiratory Immunization and Affects the Magnitude and Memory Subsets of Vaccine-Generated Mucosal and Systemic CD8+ T Cells in a Diameter-Dependent Manner
Published in Molecular pharmaceutics (01-05-2017)“…The diameter of biodegradable particles used to coencapsulate immunostimulants and subunit vaccines affects the magnitude of memory CD8+ T cells generated by…”
Get full text
Journal Article -
9
Complexation of Chol-DsiRNA in place of Chol-siRNA greatly increases the duration of mRNA suppression by polyplexes of PLL(30)-PEG(5K) in primary murine syngeneic breast tumors after i.v. administration
Published in International journal of pharmaceutics (30-05-2018)“…[Display omitted] RNA interference has tremendous potential for cancer therapy but is limited by the insufficient potency of RNAi molecules after i.v…”
Get full text
Journal Article -
10
Peripherally Cross-Linking the Shell of Core-Shell Polymer Micelles Decreases Premature Release of Physically Loaded Combretastatin A4 in Whole Blood and Increases its Mean Residence Time and Subsequent Potency Against Primary Murine Breast Tumors After IV Administration
Published in Pharmaceutical research (01-03-2015)“…ABSTRACT Purpose Determine the feasibility and potential benefit of peripherally cross-linking the shell of core-shell polymer micelles on the premature…”
Get full text
Journal Article -
11
The modification of siRNA with 3′ cholesterol to increase nuclease protection and suppression of native mRNA by select siRNA polyplexes
Published in Biomaterials (01-02-2011)“…Abstract Polymer-siRNA complexes (siRNA polyplexes) are being actively developed to improve the therapeutic application of siRNA. A major limitation for many…”
Get full text
Journal Article -
12
Cell-mediated transfer of catalase nanoparticles from macrophages to brain endothelial, glial and neuronal cells
Published in Nanomedicine (London, England) (01-09-2011)“…Our laboratories forged the concept of macrophage delivery of protein antioxidants to attenuate neuroinflammation and nigrostriatal neurodegeneration in…”
Get more information
Journal Article -
13
The efficacy of nuclease-resistant Chol-siRNA in primary breast tumors following complexation with PLL-PEG(5K)
Published in Biomaterials (01-07-2013)“…Abstract Modifying the sense strand of nuclease-resistant siRNA with 3′-cholesterol (Chol-*siRNA) increases mRNA suppression after i.v. administration but with…”
Get full text
Journal Article -
14
Targeted Amino Acid Substitution Overcomes Scale-Up Challenges with the Human C5a-Derived Decapeptide Immunostimulant EP67
Published in ACS infectious diseases (08-05-2020)“…EP67 is a second-generation, human C5a-derived decapeptide agonist of C5a receptor 1 (C5aR1/CD88) that selectively activates mononuclear phagocytes over…”
Get full text
Journal Article -
15
Effects of the PPARγ agonist troglitazone on endothelial cells in vivo and in vitro: Differences between human and mouse
Published in Toxicology and applied pharmacology (15-05-2009)“…Peroxisome proliferator-activated receptor gamma (PPARγ) agonists and PPARγ/α dual agonists have been or are being developed for clinical use in the treatment…”
Get full text
Journal Article -
16
The Specificity in Vivo of Two Distinct Methionine Aminopeptidases in Saccharomyces cerevisiae
Published in Archives of biochemistry and biophysics (01-02-2002)“…In Saccharomyces cerevisiae, the essential function of amino-terminal methionine removal is provided cotranslationally by two methionine aminopeptidases…”
Get full text
Journal Article -
17
Structure/function analysis of peptoid/lipitoid:DNA complexes
Published in Journal of pharmaceutical sciences (01-09-2003)“…Previous transfection studies of cationic peptoid polymers (N-substituted polyglycines) and cationic lipitoid polymers (peptoid-phospholipid conjugates) have…”
Get more information
Journal Article -
18
Evidence of a dominant negative mutant of yeast methionine aminopeptidase type 2 in Saccharomyces cerevisiae
Published in Journal of cellular biochemistry (01-03-2005)“…Eukaryotic methionine aminopeptidase type 2 (MetAP2, MetAP2 gene (MAP2)), together with eukaryotic MetAP1, cotranslationally hydrolyzes initiator methionine…”
Get full text
Journal Article -
19
Musocal vaccine for universal influenza A protection
Published in The Journal of immunology (1950) (01-05-2016)“…The rapid mutation rate of the influenza virus requires that the yearly flu vaccine development cycle start months in advance of the flu season. The search for…”
Get full text
Journal Article -
20
The modification of siRNA with 3a super(2) cholesterol to increase nuclease protection and suppression of native mRNA by select siRNA polyplexes
Published in Biomaterials (01-02-2011)“…Polymer-siRNA complexes (siRNA polyplexes) are being actively developed to improve the therapeutic application of siRNA. A major limitation for many siRNA…”
Get full text
Journal Article